The FDA approved Neupro (Rotigotine Transdermal System) for the treatment of Parkinson's disease and restless leg syndrome.
Jocelyn Thomas, PharmD
Advertisement
Articles by Jocelyn Thomas, PharmD
Advertisement
Latest Updated Articles
- Forest Laboratories' Viibryd
August 10th 2011
- New FDA Actions: UCB's Neupro
July 10th 2012
Advertisement
Advertisement
Trending on Pharmacy Times
1
Phase 3 MonumenTAL-3 Trial Demonstrates Significant Survival Benefit With Talquetamab-Based Regimens in Relapsed/Refractory Multiple Myeloma
2
Metformin Cuts Long COVID Risk by 50%, New Trial Confirms
3
ADA 2026: Key Pharmacotherapy Advances in Type 1 and Type 2 Diabetes
4
FDA Approves Capvaxive Expanded Indication to Include Children, Adolescents at Increased Risk for Pneumococcal Disease
5